000			01830nam a22002537a 4500
003			ISI Library, Kolkata
005			20240918125347.0
008			240718b |||||||| |||| 00| 0 eng d
020			_a9241207418
040			_aISI Library _bEnglish
082	0	4	_a100 SD:610.621 _bWHO.Tr.741
110	1		_aWHO Expert Committee on Drug Dependence
245	1	0	_aWHO Expert Committee on Drug Dependence : twenty-third report, meeting held in Geneva from 22 to 28 April 1986
260			_aGeneva : _bWorld Health Organization, _c1987
300			_a64 Pages; _c20 cm.
490	0		_aWorld Health Organization technical report series ; no. 741
505	0		_aIntroduction -- 1. General Considerations -- 2. Methods used in assessing the thirty-one barbiturates -- 3. assessment of individual substances -- 4. Recommendations
520			_aAssesses data on 31 barbiturates in order to determine which of these substances should be recommended for international control. Barbiturates are classified in three main groups: ultra-short-acting barbiturates used as intravenous anaesthetics or for the induction of anaesthesia, the intermediate-acting barbiturates used mainly as hypnotics and daytime sedatives, and other longer-acting substances used in the management of epilepsy. Five of the 31 substances are recommended for placement in Schedule III or IV. A concluding section, devoted to recommendations for improving review procedures, discusses the problems caused by the difficulty of obtaining phenobarbital in many developing countries, especially in view of the effectiveness of this Schedule IV substance in the treatment of epilepsy.
650		4	_aSubstance-Related Disorders
650		4	_aBarbiturates
650		4	_aCommunity Health and Primary Health Care
710	1		_aWorld Health Organization
942			_2ddc _cRP
999			_c435051 _d435051